T. Rowe Price Health Sciences Fund, Inc. (PRHSX) is an MF managed by T. Rowe Price. Its largest position is ELI LILLY & Co (LLY), representing 10.14% of fund assets.
T. Rowe Price Health Sciences Fund, Inc. Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- PRHSX
- Type:
- MF
- Manager:
- T. Rowe Price
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
10.14% | $1,104,163,650.06 | 1,200,478 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
4.07% | $442,858,207.87 | 900,979 |
|
-
INTUITIVE SURGICAL INC
|
3.65% | $397,936,248.79 | 863,221 |
|
-
STRYKER CORP
|
3.46% | $377,064,253.98 | 1,147,522 |
|
-
Merck & Co., Inc.
|
3.44% | $374,870,793.68 | 3,116,392 |
|
-
ASTRAZENECA PLC
|
3.17% | $345,378,566.70 | 1,751,235 |
|
-
UNITEDHEALTH GROUP INC
|
3.09% | $336,306,840.35 | 1,242,865 |
|
-
ARGENX SE
|
2.92% | $317,885,127.50 | 435,310 |
|
-
AbbVie Inc.
|
2.84% | $309,562,434.09 | 1,423,341 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
2.65% | $288,369,336.64 | 373,226 |
|
-
GILEAD SCIENCES, INC.
|
2.60% | $283,595,093.32 | 2,034,836 |
|
-
JOHNSON & JOHNSON
|
2.44% | $266,037,496.20 | 1,088,355 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.42% | $264,036,869.30 | 591,295 |
|
-
DANAHER CORP /DE/
|
2.05% | $222,869,301.60 | 1,175,471 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.62% | $175,987,767.78 | 531,894 |
|
-
Ascendis Pharma A/S
|
1.42% | $154,661,050.29 | 676,173 |
|
-
Revolution Medicines, Inc.
|
1.36% | $147,792,964.50 | 1,519,722 |
|
-
UNITED THERAPEUTICS Corp
|
1.34% | $146,432,260.14 | 246,943 |
|
-
BeOne Medicines Ltd.
|
1.19% | $129,161,256.95 | 5,757,796 |
|
-
Roivant Sciences Ltd.
|
1.13% | $123,200,542.10 | 4,447,673 |
|
-
Protagonist Therapeutics, Inc
|
1.11% | $120,373,018.60 | 1,142,059 |
|
-
INSMED Inc
|
1.05% | $114,904,686.40 | 702,695 |
|
-
Summit Therapeutics Inc.
|
1.04% | $112,780,204.08 | 5,948,323 |
|
-
Natera, Inc.
|
1.03% | $112,343,582.54 | 561,746 |
|
-
TENET HEALTHCARE CORP
|
1.00% | $109,471,048.42 | 580,102 |
|
-
BrightSpring Health Services, Inc.
|
0.98% | $107,124,820.97 | 2,514,077 |
|
-
AMGEN INC
|
0.98% | $106,864,585.70 | 303,722 |
|
-
BOSTON SCIENTIFIC CORP
|
0.92% | $100,636,630.25 | 1,603,771 |
|
-
HCA Healthcare, Inc.
|
0.90% | $97,589,186.60 | 206,215 |
|
-
Guardant Health, Inc.
|
0.90% | $97,541,611.56 | 1,055,988 |
|
-
CVS HEALTH Corp
|
0.86% | $94,108,546.98 | 1,310,339 |
|
-
Kymera Therapeutics, Inc.
|
0.77% | $83,487,147.43 | 1,002,367 |
|
-
Cigna Group
|
0.74% | $80,106,092.00 | 300,304 |
|
-
CG Oncology, Inc.
|
0.69% | $75,028,220.64 | 1,108,573 |
|
-
CARDINAL HEALTH INC
|
0.68% | $73,584,903.92 | 348,232 |
|
-
Elevance Health, Inc.
|
0.66% | $71,512,384.50 | 244,278 |
|
-
Krystal Biotech, Inc.
|
0.65% | $70,637,862.32 | 273,451 |
|
-
Scholar Rock Holding Corp
|
0.62% | $67,338,384.80 | 1,369,780 |
|
-
IONIS PHARMACEUTICALS INC
|
0.61% | $66,291,179.07 | 882,823 |
|
-
BridgeBio Pharma, Inc.
|
0.59% | $64,171,704.74 | 864,149 |
|
-
CHUGAI PHARMACEUTICAL CO LTD.
|
0.58% | $62,924,419.81 | 1,141,000 |
|
-
Structure Therapeutics Inc.
|
0.56% | $61,368,577.40 | 1,273,207 |
|
-
Praxis Precision Medicines, Inc.
|
0.56% | $60,990,889.19 | 189,301 |
|
-
Celcuity Inc.
|
0.56% | $60,608,340.00 | 531,000 |
|
-
ROYALTY PHARMA PLC- CL A
|
0.55% | $59,566,411.71 | 1,241,743 |
|
-
Cencora, Inc.
|
0.52% | $56,456,298.38 | 179,717 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
0.50% | $54,320,158.44 | 1,367,577 |
|
-
Vera Therapeutics, Inc.
|
0.46% | $49,716,475.38 | 1,235,806 |
|
-
NUVALENT INC-A
|
0.43% | $47,105,587.95 | 459,791 |
|
-
APOGEE THERAPEUTICS INC
|
0.43% | $46,722,598.66 | 555,098 |
Advertisement (320x50)